Pharmaceutical Technology

MARCH 16, 2023

Global biopharmaceutical firm UCB has entered an early drug discovery collaboration with Aitia. UCB executive vice-president and chief scientific officer Dhaval Patel said: “We are pleased to work with Aitia in a bid to unravel the circuity of this debilitating disease. “We

Patients 93

Patients Medicine 93

European Pharmaceutical Review

DECEMBER 14, 2022

Two biopharmaceutical companies, UCB and Praxis Precision Medicines Inc., Under the collaboration agreement, UCB will retain an exclusive option to in-license global development and commercialisation rights to any resulting KCNT1 small molecule development candidate. Small molecule therapeutics to treat KCNT1 related epilepsy.

Medicine 91

Medicine Sales Pharmaceutical 91

European Pharmaceutical Review

JANUARY 8, 2024

The European Commission (EC) has now granted a marketing authorisation for biopharma company UCB’s treatment, as an add-on to standard therapy in patients who have this rare autoimmune condition.

Biopharma 94

Biopharma Medicine Healthcare Healthcare 94

pharmaphorum

DECEMBER 14, 2022

Pharma consultancy United BioSource, or UBC (not to be confused with pharma company UCB), has promoted former chief operating officer Bekki Brown to the role of president and CEO, effective January 1. Life sciences commercialisation company Indegene has appointed Georgia Papathomas as non-executive independent director to the board.

Consulting 97

Consulting Pharma Healthcare Healthcare 97

pharmaphorum

OCTOBER 13, 2022

The therapy has been on the market in Europe since 2019, which is marketed by UCB in the region, though by Amgen and Astellas in other areas. UCB recently revealed that a study had been carried out using 3D modelling to visualise and assess on-going treatment for osteoporosis.

Marketing 88

Marketing Healthcare Healthcare Leads 88

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

Marketing 52

Marketing Education Media Healthcare 52

PM360

OCTOBER 3, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Advancing Breast Cancer Health Equity at the Point of Care” (Susan G.

Education 122

Education Marketing Media Management 122

pharmaphorum

OCTOBER 31, 2022

The decision to drop the oral ROR gamma inverse agonist – also known as ABBV-157 – came after analysis of a recently concluded nonclinical toxicology study, according to an Inventiva statement, in which the company said it does not expect the move to have any impact on its cash position.

Leads 52

Leads Pharma Patients Pharmaceutical 52

Pharmaceutical Technology

MAY 8, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

Pharmaceutical 52

Pharmaceutical Leads Side effects Medicine 52

pharmaphorum

SEPTEMBER 20, 2022

The company recorded sales of $3.25 Amgen company is seeking to defend its osteoporosis franchise with UCB-partnered Evenity (romosozumab), an anti-sclerostin antibody that was approved for postmenopausal osteoporosis in 2019 and brought in $530 million last year – a rise of more than 50%.

Medicine 52

Medicine Safety Marketing Biopharma 52

Pharmaceutical Technology

MAY 15, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

pharmaphorum

SEPTEMBER 8, 2022

DiME hopes nocturnal scratch will offer pharmaceutical companies “the tools needed to de-risk the selection” of the endpoint. As yet, no new medical product has been approved on the basis of a digital endpoint.

Medical 52

Medical Medicine Healthcare Healthcare 52

pharmaphorum

NOVEMBER 14, 2022

The cash injection from the UK and Singapore-based biotech’s existing shareholders adds to $64 million raised in 2021 via an earlier rights issue, and comes a couple of weeks before the company is due to present its LUCIDITY data on full at the Clinical Trials on Alzheimer’s Disease (CTAD) conference in San Francisco on 30 November.

Transportation 52

Transportation Pharma Patients Pharmaceutical 52

pharmaphorum

OCTOBER 19, 2022

The dark genome – a loose term that covers non-coding regions of the genome that are capable of regulating the expression of genes, previously rather inaccurately referred to as junk DNA – is increasingly being explored by biopharma companies for new drug targets. Main image by LaCasadeGoethe from Pixabay . The post Nucleome raises £37.5m

Biopharma 57

Biopharma Medicine Patients 57

Pharmaceutical Technology

DECEMBER 19, 2022

This consists of any projects that have expanded the company’s footprint in the sector, including: contract wins; launching in new territories; launching new product lines; the acquisition and expansion of facilities and real estate; acquisition of new machinery or other assets; improved logistics; partnerships; and significant staff increases.

Marketing 52

Marketing Sales Strategy Manufacturing Pharmaceutical 52

pharmaphorum

OCTOBER 7, 2022

TauRx Pharma’s effort to bring a tau-targeting drug for Alzheimer’s disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be getting closer to the finishing line. After 12 months’ treatment, there was “minimal decline” in the HMTM group – 1.3

FDA 85

FDA Transportation Patients Prospecting 85

PM360

MAY 15, 2023

Digital Crusaders: Those who advance digital channel applications or platforms to transform marketing and/or company operations. Entrepreneurs: Visionary risk-takers who develop new companies to answer unmet needs. Sales MVPs : Company sales leaders who do an outstanding job of building revenue and nurturing company growth.

Education 105

Education Media Marketing Sales 105

Pharma Marketing Network

FEBRUARY 10, 2022

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1.

Pharma 52

Pharma Marketing Management Networking 52

Pharma Marketing Network

FEBRUARY 10, 2022

Change champions from top life sciences companies discussed how to manage the constant wave of change pharma marketing teams are facing at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about preparing your pharma marketing team for change in 2022: 1.

Pharma 52

Pharma Marketing Management Networking 52

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e. Revolutionisation through digital commercialisation.

Pharma 92

Pharma Consulting Marketing Sales 92

Pharmaceutical Technology

DECEMBER 22, 2022

The programme provides a platform to recognise the people and companies that are driving change. Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community. Business Expansion.

Medicine 52

Medicine Marketing Pharmaceutical Manufacturing 52

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Education 52

Education Marketing Media Biopharma 52

PM360

MAY 16, 2023

1 GI company in the U.S. As he leads Ironwood, his company is working on even more advancements in this space that could lead to first-time treatments within their categories and help even more patients get the care they deserve.” His most recent accomplishments include leading the growth of Ironwood in its quest to become the No.

Media 52

Media Marketing Management Pharmaceutical 52

European Pharmaceutical Review

JULY 12, 2023

CEOS from three Big Pharma companies: Pfizer, Roche and Daiichi Sankyo will join IFPMA’s team. Albert Bourla, currently Vice-President of IFPMA, assumes the role from Jean-Christophe Tellier, CEO and Chairman of UCB, who has worked in the role since January 2021. Who is joining IFPMA’s new CEO leadership team?

Pharmaceutical manufacturing 91

Pharmaceutical manufacturing Manufacturing Government Pharma 91

Pharma Marketing Network

DECEMBER 14, 2020

There were 5 finalists from the following companies: Takeda, Biogen, Servier, AstraZeneca, and ACTO. The winner for the Patient Champion Award for Pharma, was for an individual or group who has worked to make patient’s lives easier from within a pharmaceutical company. . Entrepreneur Award: Health Solution.

Pharma 52

Pharma Education Healthcare Healthcare 52

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. What are the current three main challenges in clinical trials?

Safety 102

Safety Electronics Recruitment Medical 102

Pharmaceutical Technology

MAY 25, 2023

Medications module to help medication adherence Huma is a global healthcare company using digital technology to transform treatments with the “world’s first” digital health multi-disease platform regulated under European Union MDR (Medical Device Regulation) Class IIb.

Medicine 52

Medicine Side effects Healthcare Provider Education 52

Pharmaceutical Technology

MAY 11, 2023

Ariceum Therapeutics has entered into an exclusive strategic research collaboration agreement with UCB to discover and develop new systemic targeted radiopharmaceuticals to treat immune-related diseases and solid tumours. This research collaboration gives Ariceum and UCB the opportunity to explore multiple targets.

Leads 52

Leads Pharmaceutical Marketing 52

Pharmaceutical Technology

MARCH 9, 2023

Global biopharmaceutical firm UCB and Cancer Research UK have entered a multi-project partnership to advance two of the former’s oncology antibody candidates through clinical trials. It will combine Cancer Research UK’s oncology-focused translational research and clinical development capabilities and the antibody discovery expertise of UCB.

Leads 52

Leads Pharmaceutical Networking Manufacturing 52